Logo image of AZRN.AS

AZERION GROUP N.V. (AZRN.AS) Stock Fundamental Analysis

AMS:AZRN - Euronext Amsterdam - NL00150006Z9 - Common Stock - Currency: EUR

1.15  +0.02 (+2.22%)

Fundamental Rating

1

AZRN gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 20 industry peers in the Interactive Media & Services industry. AZRN may be in some trouble as it scores bad on both profitability and health. AZRN has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year AZRN has reported negative net income.
In the past year AZRN has reported a negative cash flow from operations.
AZRN.AS Yearly Net Income VS EBIT VS OCF VS FCFAZRN.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 -50M -100M

1.2 Ratios

AZRN has a worse Return On Assets (-8.58%) than 75.00% of its industry peers.
AZRN has a Return On Equity of -153.55%. This is in the lower half of the industry: AZRN underperforms 75.00% of its industry peers.
Industry RankSector Rank
ROA -8.58%
ROE -153.55%
ROIC N/A
ROA(3y)-8.64%
ROA(5y)N/A
ROE(3y)-78.44%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AZRN.AS Yearly ROA, ROE, ROICAZRN.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 100 -100

1.3 Margins

AZRN has a Gross Margin of 31.92%. This is amonst the worse of the industry: AZRN underperforms 80.00% of its industry peers.
AZRN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 31.92%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AZRN.AS Yearly Profit, Operating, Gross MarginsAZRN.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 20 -20 40 60

More info and screens

0

2. Health

2.1 Basic Checks

AZRN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for AZRN has been increased compared to 1 year ago.
The debt/assets ratio for AZRN is higher compared to a year ago.
AZRN.AS Yearly Shares OutstandingAZRN.AS Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 20M 40M 60M 80M 100M
AZRN.AS Yearly Total Debt VS Total AssetsAZRN.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

AZRN has an Altman-Z score of 0.52. This is a bad value and indicates that AZRN is not financially healthy and even has some risk of bankruptcy.
AZRN has a worse Altman-Z score (0.52) than 75.00% of its industry peers.
A Debt/Equity ratio of 7.33 is on the high side and indicates that AZRN has dependencies on debt financing.
With a Debt to Equity ratio value of 7.33, AZRN is not doing good in the industry: 75.00% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 7.33
Debt/FCF N/A
Altman-Z 0.52
ROIC/WACCN/A
WACC9.13%
AZRN.AS Yearly LT Debt VS Equity VS FCFAZRN.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 50M 100M 150M 200M 250M

2.3 Liquidity

A Current Ratio of 0.80 indicates that AZRN may have some problems paying its short term obligations.
With a Current ratio value of 0.80, AZRN is not doing good in the industry: 75.00% of the companies in the same industry are doing better.
AZRN has a Quick Ratio of 0.80. This is a bad value and indicates that AZRN is not financially healthy enough and could expect problems in meeting its short term obligations.
AZRN has a Quick ratio of 0.80. This is in the lower half of the industry: AZRN underperforms 75.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.8
Quick Ratio 0.8
AZRN.AS Yearly Current Assets VS Current LiabilitesAZRN.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 100M 200M 300M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for AZRN have decreased strongly by -384.65% in the last year.
The Revenue has been growing slightly by 7.18% in the past year.
EPS 1Y (TTM)-384.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%11.09%
Revenue 1Y (TTM)7.18%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%6.93%

3.2 Future

Based on estimates for the next years, AZRN will show a very strong growth in Earnings Per Share. The EPS will grow by 67.33% on average per year.
The Revenue is expected to grow by 8.50% on average over the next years. This is quite good.
EPS Next Y80%
EPS Next 2Y67.33%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year10.04%
Revenue Next 2Y9.29%
Revenue Next 3Y8.5%
Revenue Next 5YN/A

3.3 Evolution

AZRN.AS Yearly Revenue VS EstimatesAZRN.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 200M 400M 600M
AZRN.AS Yearly EPS VS EstimatesAZRN.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 0 0.05 -0.05 0.1 -0.1

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AZRN. In the last year negative earnings were reported.
AZRN is valuated correctly with a Price/Forward Earnings ratio of 14.09.
AZRN's Price/Forward Earnings ratio is rather cheap when compared to the industry. AZRN is cheaper than 90.00% of the companies in the same industry.
AZRN's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 36.44.
Industry RankSector Rank
PE N/A
Fwd PE 14.09
AZRN.AS Price Earnings VS Forward Price EarningsAZRN.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

AZRN's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. AZRN is cheaper than 75.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 13.27
AZRN.AS Per share dataAZRN.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as AZRN's earnings are expected to grow with 67.33% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y67.33%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

AZRN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AZERION GROUP N.V.

AMS:AZRN (7/18/2025, 7:00:00 PM)

1.15

+0.02 (+2.22%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryInteractive Media & Services
Earnings (Last)05-28 2025-05-28
Earnings (Next)08-28 2025-08-28
Inst Owners0.02%
Inst Owner ChangeN/A
Ins Owners45.38%
Ins Owner ChangeN/A
Market Cap141.30M
Analysts82.86
Price Target2.04 (77.39%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-31.03%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.5%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 14.09
P/S 0.25
P/FCF N/A
P/OCF N/A
P/B 3.86
P/tB N/A
EV/EBITDA 13.27
EPS(TTM)-0.47
EYN/A
EPS(NY)0.08
Fwd EY7.1%
FCF(TTM)-0.22
FCFYN/A
OCF(TTM)-0.06
OCFYN/A
SpS4.55
BVpS0.3
TBVpS-2.62
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -8.58%
ROE -153.55%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 31.92%
FCFM N/A
ROA(3y)-8.64%
ROA(5y)N/A
ROE(3y)-78.44%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.85
Health
Industry RankSector Rank
Debt/Equity 7.33
Debt/FCF N/A
Debt/EBITDA 10.04
Cap/Depr 39.76%
Cap/Sales 3.61%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.8
Quick Ratio 0.8
Altman-Z 0.52
F-Score3
WACC9.13%
ROIC/WACCN/A
Cap/Depr(3y)51.36%
Cap/Depr(5y)N/A
Cap/Sales(3y)4.46%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-384.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%11.09%
EPS Next Y80%
EPS Next 2Y67.33%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)7.18%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%6.93%
Revenue Next Year10.04%
Revenue Next 2Y9.29%
Revenue Next 3Y8.5%
Revenue Next 5YN/A
EBIT growth 1Y-132.22%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year55%
EBIT Next 3Y27.65%
EBIT Next 5YN/A
FCF growth 1Y-151.79%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-84.37%
OCF growth 3YN/A
OCF growth 5YN/A